| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Research Center and Department of Medicine, Montreal Heart Institute and University of Montreal (D.L., L.Z., S.N.), and the Department of Pharmacology and Therapeutics, McGill University (J.K., S.N.), Montreal, Quebec, Canada.
Correspondence to Dr Stanley Nattel, Research Center, Montreal Heart Institute, 5000 Belanger St E, Montreal, Quebec, Canada H1T 1C8. E-mail nattel{at}icm.umontreal.ca
Abstract
AbstractExperimental and clinical evidence suggests a critical role for the left atrium (LA) in atrial fibrillation (AF). In animal models, repolarization is faster in the LA than in the right atrium (RA), leading to more stable reentry circuits with a shorter intrinsic period in the LA. The ionic mechanisms underlying LA-RA repolarization differences are unknown. Therefore, we evaluated ionic currents and action potentials (APs) with the whole-cell patch clamp in isolated canine atrial myocytes. The density of the rapid delayed rectifier current (IKr) was greater in the LA (eg, 1.83±0.10 pA/pF at +20 mV) than in the RA (1.15±0.07 pA/pF, P<0.01; n=16 cells per group). The slow and ultrarapid delayed rectifier, the inward rectifier, L-type Ca2+, and transient outward K+ currents were all comparable in the LA and RA. There were no differences in kinetic or voltage-dependent properties of currents in LA versus RA. Western blots of ether-a-go-gorelated gene (ERG) protein in three RA and corresponding LA regions showed significantly greater ERG expression in LA. AP duration (APD) was shorter in the LA versus RA in both isolated cells and multicellular preparations, and the effective refractory period (ERP) was shorter in the LA compared with the RA in vivo. Dofetilide had significantly larger APD- and ERP-increasing effects in the LA compared with RA, and LA-RA repolarization differences were eliminated by exposure to dofetilide. We conclude that LA myocytes have larger IKr than do RA myocytes, contributing importantly to the shorter APD and ERP in LA. The larger LA IKr may participate in the ability of the LA to act as a "driver region" for AF, with potentially important implications for understanding AF mechanisms and antiarrhythmic therapy.
Key Words: channels heterogeneity electrophysiology
Several lines of evidence point to a particularly important role of the left atrium (LA) in maintaining atrial fibrillation (AF). Animal models1 2 and clinical studies3 suggest the presence of LA "driver regions" in AF. In an isolated sheep-heart model of AF, rotors maintaining the arrhythmia were always located in the LA.4 Linear LA lesions appear particularly important for the success of radiofrequency ablation procedures directed against AF.5 LA refractoriness is shorter than right atrial (RA) refractoriness,6 7 8 potentially explaining, at least in part, the preferential role of LA reentry in AF. Despite the evidence for differences between LA and RA refractoriness that might be important in the pathophysiology of AF, there are no published studies comparing the cellular ionic electrophysiology of LA with RA myocytes. The present work was designed to evaluate action potential (AP) properties and ionic currents governing repolarization in canine cells isolated from the LA free wall and to compare them with RA cells. Because our findings pointed to an important role for differences in rapid delayed rectifier current (IKr) between LA and RA, we also evaluated the effect of the IKr blocker dofetilide on differences between RA and LA electrophysiology in both multicellular atrial preparations and the in situ heart.
Materials and Methods
Cell Isolation and Patch-Clamp Methods
Hearts were excised from 33 dogs (25.6±3.2 kg)
anesthetized with pentobarbital (30 mg/kg IV) and immersed in
Tyrodes solution containing 2 mmol/L
Ca2+. All tissues for dissection and
perfusion were equilibrated with 100% O2.
Atrial myocytes were isolated as in previous
studies.9 10 The
right coronary artery (to perfuse the RA free wall) and left
circumflex coronary artery (to perfuse the LA free wall) were
cannulated and removed along with the perfused segments of atrial
tissue. The tissues were then perfused with Tyrodes solution at
37°C until the effluent was clear of blood, followed by perfusion at
12 mL/min with Ca2+-free Tyrodes solution
for 20 minutes and then with the same solution containing
collagenase (CLSII, 100 U/mL, Worthington) and 1% BSA.
When tissues were softened, a section was minced, and cells were
harvested by trituration. Cells were kept at room temperature in a
high-K+ storage solution until they were
used.
Cells in a 1-mL bath were superfused (3 mL/min, 35°C) with an extracellular Tyrodes solution containing (mmol/L) NaCl 136, KCl 5.4, CaCl2 2, MgCl2 0.8, NaH2PO4 0.33, dextrose 10, and HEPES 10, pH 7.4 (NaOH). For Ca2+ current (ICa) recording, tetraethylammonium chloride and CsCl replaced NaCl and KCl, respectively. For classic delayed rectifier current (IK) studies, 2-mmol/L 4-aminopyridine was used to block transient outward current (Ito), after it was verified that 4-aminopyridine had no effect on IK tail currents. For studies of the ultrarapid delayed rectifier (IKur.d), a holding potential (HP) of -50 mV and an 80-ms prepulse to +30 mV at 10 ms before a test pulse were used to inactivate Ito as previously described.10 Ito was studied in the presence of 10 mmol/L tetraethylammonium and 1 µmol/L dofetilide to inhibit IKur.d and IK, after it was verified that neither drug affects Ito. For K+ current measurement, CdCl2 (200 µmol/L) or (for studies of IK) 5 µmol/L nifedipine was added to block ICa and the Ca2+-sensitive ICl. When HP negative to -50 mV was used in studies of K+ currents, Tris-HCl replaced NaCl. The standard pipette solution contained (mmol/L) potassium aspartate 110, KCl 20, MgCl2 1, GTP 0.1, Mg2-ATP 5, Na2-phosphocreatine 5, EGTA 10, and HEPES 10, pH 7.3 (KOH). For AP recording, the EGTA concentration was decreased to 50 µmol/L. For ICa recording, K+ was replaced by Cs+. The storage solution contained (mmol/L) KCl 20, KH2PO4 10, glutamic acid 70, ß-hydroxybutyric acid 10, taurine 10, EGTA 10, and dextrose 10, along with 1% albumin (pH 7.4 with KOH or CsOH).
To minimize the potential effects of time-dependent changes in enzymes and isolation procedure over the course of the present study, LA and RA cells were studied concurrently in an alternating fashion. Cells from both LA and RA from each dog were evaluated with the same voltage-clamp protocols to study the same currents on each experimental day. To minimize any potential contaminating effect of current rundown (particularly for IK and ICa), the current protocols were applied in the same order for LA and RA cells. Five minutes were allowed for stabilization after membrane rupture before recording, and if currents varied by >5% over the course of a protocol, the data were rejected.
Tight-seal patch clamp was used to record currents
(voltage-clamp mode) and APs (current-clamp mode). Electrode
resistances were 1 to 2 M
for current recording and 3 to 5
M
for AP recording. Cells with normal resting potentials
(negative to -70 mV,
30% of all cells) were used for AP
recording. APs (elicited by 2-ms twice-threshold pulses) were
analyzed at steady state (15 to 20 APs) at each frequency.
Recordings were low-passfiltered at half the sampling
frequency (2 kHz for
IKr and
the slow delayed rectifier current
[IKs],
10 kHz for APs,
ICa, and
Ito).
Junction potentials (8 to 10 mV) were corrected for AP
recordings only. Seal resistance averaged 8.8±1.3 G
.
Pipettes had resistances of 1 to 3 M
when filled. Series resistances
and capacitance compensation were applied. Leakage correction was not
used; cells with significant leaks were rejected for study. Series
resistances and capacitive time constants averaged 7.1±0.2 M
and
512±12 µs, respectively, before compensation and 1.60±0.04 M
and
129±6 µs, respectively, after compensation. Cell capacitance (the
time integral of capacitive current divided by the voltage drop during
5-mV steps) was 81.7±2.3 pF in 164 LA cells and 72.0±1.7 pF in 164 RA
cells (P<0.01), indicating
that LA cells were larger. Therefore, current amplitudes are
presented in terms of densities.
Multicellular-Preparation AP
Recording
Hearts were excised from seven dogs (25.9±4.0 kg),
and the right and left coronary arteries were cannulated and
perfused with (mmol/L) NaCl 120, KCl 3.8, CaCl2
1.25, MgSO4 1.2,
KH2PO4 1.2,
NaHCO3 25, and dextrose 5.5,
95%O2/5%CO2 at 37°C.
RA and LA preparations (endocardial surface exposed) were fixed in a
tissue bath, and the tissue was perfused at 12 to 14 mL/min. APs were
recorded from the RA pectinate muscles (same region as for cell
isolation) or the LA free wall at 1 Hz via 3 mol/L KClfilled floating
microelectrodes (10 to 30 M
) and an Axoclamp-2B amplifier (Axon),
before and after addition of 1 µmol/L dofetilide to the
bath.
In Vivo Study
Dogs weighing 26.3±3.7 kg (n=8) were
anesthetized with morphine (2 mg/kg SC) and
-chloralose (120
mg/kg IV bolus, followed by 29.25 mg/kg per hour). A median sternotomy
was performed, and bipolar
polytetrafluoroethylene (Teflon)-coated
stainless-steel electrodes were hooked into RA and LA free walls for
recording and stimulation. The effective refractory period
(ERP) was measured with 15 basic (S1) stimuli followed by a premature
(S2) stimulus (all stimuli were 2-ms, twice threshold) with 5-ms S1S2
decrements (ERP is the longest S1S2 failing to capture, mean of three
determinations). LA and RA ERPs were measured before and after 80
µg/kg of intravenous dofetilide
(Pfizer).
Immunoblotting of ERG
Protein
Ether-a-go-gorelated gene (ERG) proteins
were extracted from three regions (appendage, free wall, and posterior
wall) of the RA and LA of eight dogs not used for other studies. Atrial
tissues were removed from hearts excised under pentobarbital
anesthesia, with tissue blocks excised rapidly in Tyrodes
solution, frozen in liquid nitrogen, and stored at -80°C for
subsequent analysis. To extract membrane protein,
2 g of
atrial tissue was pulverized in liquid nitrogen and suspended in 3 mL
ice-cold RIPA buffer containing (mmol/L) dibasic sodium phosphate 9.1,
monobasic sodium phosphate 1.7, dithiothreitol 5, NaCl 150, and sodium
orthovanadate 100, along with 1% Igepal CA-630 (Sigma), 0.5% sodium
deoxycholate, 0.1% SDS, 0.1 mg/mL benzamidine, 10 mg/mL
phenylmethylsulfonyl fluoride, 5 µg/mL leupeptin, 5 µg/mL
pepstatin A, and 5 µg/mL aprotinin. The suspension was
homogenized and then centrifuged at
14 000g for 20 minutes at
4°C. The soluble fraction was retained and stored at -80°C.
Protein concentration was determined by the Bradford method, with BSA
used as the standard.
Protein extracts (60 µg) were denatured in Laemmli sample buffer and subjected to electrophoresis on 7.5% SDS-polyacrylamide gels. Proteins were transferred to Immobilon-P polyvinylidene difluoride membranes blocked with 5% nonfat dry milk in Tris-buffered saline solution (TBS) and incubated overnight with anti-ERG primary antibody (Alomone) at a 1:200 dilution. The primary antibody was a polyclonal preparation from rabbits hyperimmunized against the C-terminal domain of human ERG1 (residues 1118 to 1133). Protein samples probed with primary antibody that had been preincubated with the antigenic peptide were used as negative controls. After having been washed 5 times in 0.1% Tween 80TBS (TTBS), the membranes were reblocked in 1% nonfat dry milk in TTBS for 10 minutes. They were then incubated in a 1:8000 dilution of horseradish peroxidaseconjugated anti-rabbit IgG in 1% nonfat dry milk in TTBS for 60 minutes, followed by four additional washes in TTBS. Antibody detection was performed with Western Blot Chemiluminescence Reagent Plus (NEN Life Sciences). A single band corresponding to ERG with the expected molecular mass of 160 kDa was detected. The density of bands was quantified by laser densitometry with Quality One software. Densitometric comparisons of different groups were performed on blots processed equally and exposed on the same x-ray film.
Statistical Analysis
Data are presented as mean±SEM. Nonlinear
curve fitting was performed with pCLAMP6 (Clampfit, Chebyshev
algorithm). Paired t tests and
nonpaired t tests (2-tailed)
were used to compare baseline and drug responses and LA and RA cells,
respectively.
Results
AP Recordings and In Vivo ERP
Figures 1A
and 1B
show all APs recorded from
isolated RA and LA myocytes, respectively. Overall AP morphology was
similar in both regions, but LA AP duration (APD) was significantly
shorter
(Figure 1C
). AP amplitude and resting potential were similar
for RA and LA
(Table
).
In agreement with AP recordings, LA ERP was significantly
shorter in vivo than RA ERP
(Figure 1D
). Standard microelectrode recordings from
multicellular RA and LA preparations are shown in
Figures 1E
and 1F
, with LA APD being consistently
shorter than RA
(Figure 1G
).
|
|
K+ Currents
Inward Rectifier Current,
IK1
The inward rectifier current
(IK1)
was isolated by applying step pulses from HP of -40 mV before and
after 0.5 mmol/L Ba2+ and by obtaining
Ba2+-sensitive currents by digital
subtraction.
Figures 2A
and 2B
show
Ba2+-sensitive
IK1
recordings in RA and LA cells, respectively. The
IK1
density-voltage relation (based on end-pulse current) showed no
differences between RA and LA
(Figure 2C
).
|
Ultrarapid Delayed Rectifier Current,
IKur.d
Typical
IKur.d
recordings from RA and LA cells are shown in
Figures 2D
and 2E
and show the rapid activation, inward
rectification at positive voltages, and tail currents characteristic of
the current. There were no differences in the form of currents in RA
versus LA. As shown in
Figure 2F
, mean
IKur.d
step and tail densities in 12 LA and 12 RA cells showed no significant
differences.
Transient Outward Current,
Ito
Figures 3A
and 3B
show recordings of
Ito from
RA and LA, respectively. Current amplitude was measured as the
difference between peak current on depolarization and end-pulse
steady-state current.
Ito
density-voltage relations
(Figure 3C
) and normalized current-voltage relations
(Figure 3D
) were superimposable for LA and RA. Similarly,
Ito
voltage-dependent activation and inactivation showed no RA-LA
differences
(Figure 3E
). Half-activation voltage averaged 10.2±0.9 mV in
LA and 11.7±0.4 mV in RA; half-inactivation voltage averaged
-25.1±1.9 mV in LA and -25.4±0.8 mV in RA.
Figure 3F
illustrates
Ito
recovery at -70 mV as determined with a paired-pulse protocol. Time
constants averaged 35.5±3.0 (-70 mV), 56.5±6.5 (-60 mV), and
90.4±8.3 (-50 mV) ms in LA and 34.2±3.2 (-70 mV), 59.0±7.6
(-60 mV), and 92.7±8.8 (-50 mV) ms in RA, with no significant
RA-LA differences (n=10 cells at each voltage per
group.)
|
Slow Delayed Rectifier Current,
IKs
Figures 4A
and 4B
show
IKs
recorded from RA and LA myocytes in the presence of 1 µmol/L
dofetilide to inhibit
IKr.
Mean step and tail-current density-voltage relations
(Figures 4C
and 4D
, respectively) were the same for LA and RA.
The voltage dependence of
IKs
activation was evaluated from the normalized
tail-current/test-potential relation
(Figure 4E
). Half-activation voltages averaged 17.2±1.2 (LA)
and 18.3±1.9 mV (RA, P=NS).
IKs
activation was well-fit by biexponential functions (correlation
coefficients >0.99). Mean activation time constants did not differ
between RA and LA
(Figure 4F
). Similarly, there were no significant differences
in deactivation time constants: tail time constants averaged 87.7±4.6
and 370.4±35.8 ms in LA versus 84.4±3.1 ms and 344.2±31.4 ms in RA
(P=NS).
|
Rapid Delayed Rectifier Current,
IKr
The protocol shown in
Figure 5
was used to record
IK
before and after 1 µmol/L dofetilide, with
IKr
obtained as the dofetilide-sensitive current. Recordings from
RA and LA myocytes are shown in panels A and B, respectively.
IKr was
consistently and significantly larger in LA cells
(Figures 5C
and 5D
). For example, at a test potential of +20
mV, step current density averaged 1.83±0.10 pA/pF in LA cells; this
value was 60% larger than the value of 1.15±0.07 pA/pF in RA cells
(P<0.01). Tail current density
after a pulse to +20 mV averaged 0.99±0.10 pA/pF in LA versus
0.75±0.06 pA/pF in RA
(P<0.05).
IKr
activation voltage dependence was similar for LA and RA
(Figure 5E
). Half-activation voltages were -10.1±1.6 mV
(LA) and -9.4±1.3 mV (RA,
P=NS).
IKr
activation was monoexponential, with a time constant at
+10 mV averaging 138±16 ms in LA and 134±10 ms in RA
(Figure 5F
, P=NS).
Deactivation was biexponential, with tail-current time constants at
-30 mV (after a pulse to +10 mV) of 313±38 and 3851±259 ms in LA
and 311±47 and 3719±323 ms in RA
(P=NS).
|
L-Type Ca2+ Current,
ICa
Typical
ICa
recordings in RA and LA cells are shown in
Figures 6A
and 6B
. There were no significant differences in
ICa
density between RA and LA
(Figure 6C
) or in the normalized current-voltage relationship
(Figure 6D
).
ICa
inactivation voltage dependence
(Figure 6E
) was explored with 1-second prepulses to various
voltages, followed by 300-ms test pulses to +10 mV (HP -80 mV, 0.1
Hz). Half-inactivation voltage averaged -25.2±1.3 mV in LA cells and
-25.5±1.9 mV in RA cells (n=10 per group,
P=NS). The activation voltage
dependence was assessed by dividing peak current during test pulses by
the driving force (difference between test potential and
ICa
reversal potential). The half-activation voltage averaged -9.6±7.1
mV in LA and -9.5±1.7 mV in RA
(P=NS).
ICa
recovery kinetics were studied with a 2-pulse protocol as shown in
Figure 6F
. Monoexponential recovery time
constants averaged 32.7±2.3 ms in LA and 30.0±2.5 ms in RA
(P=NS).
|
Response to Dofetilide
If the differences between RA and LA repolarization
were primarily due to differences in
IKr, as
suggested by the voltage-clamp results, blockade of
IKr
should equalize repolarization properties. Furthermore, if
IKr is
larger in LA,
IKr
block should increase APD and ERP to a greater extent in LA than in RA.
Therefore, we studied the effects of dofetilide at a maximally
effective
IKr-blocking
concentration, 1 µmol/L,11
on APD in multicellular atrial preparations (to avoid artifacts due to
cell isolation) in vitro and the effects of 80 µg/kg dofetilide
IV12 on ERP in vivo. Typical
results from RA and LA preparations are shown in
Figures 1E
and 1F
. Overall, mean APD at 90% repolarization
(APD90) was significantly shorter in LA
preparations under control conditions
(Figure 1G
, left), but there were no significant differences
after dofetilide. The percentage APD prolongation caused by dofetilide
in LA preparations was significantly greater than in RA
(Figure 1H
, left). Similarly, ERP in vivo was significantly
shorter in the LA before, but not after, dofetilide
(Figure 1G
, right), and dofetilide caused substantially
greater ERP increases in LA than in RA
(Figure 1H
, right).
Atrial Expression of ERG Protein
To obtain an independent assessment of interatrial
differences in expression of
IKr-related
protein, we used Western blot methods to evaluate the expression of ERG
protein.
Figure 7A
shows ERG protein detected in three RA and three
corresponding LA regions from one dog. The molecular weights were
identical in all regions, and the bands appear denser in the LA
samples. Negative controls probed with antibodies preincubated with ERG
antigen show no signals, as expected
(Figure 7B
).
Figure 7C
shows mean ERG protein densities (eight hearts per
measurement, with data for each region obtained in each heart). ERG
expression was significantly stronger in LA compared with RA
(P=0.007 for LA versus RA as a
significant determinant by 1-way
ANOVA).
|
Discussion
We have shown that APD and ERP are shorter in the LA free wall than in the RA free wall, that LA cells have a larger IKr density than do RA cells (with no differences in IKur.d, IKs, IK1, Ito, and L-type ICa), and that the IKr blocker dofetilide eliminates LA-RA repolarization differences. These findings suggest that differences in IKr play an important role in repolarization differences between the LA and RA.
Functionally Important ERP Differences Between
LA and RA
Several studies in
animal1 2 4 13
and clinical
models3 5 point to
the importance of the LA in maintaining AF. Rensma et
al14 showed that wavelength
is a significant determinant of atrial reentry, particularly AF, in
dogs, and that shorter refractory periods result in smaller wavelengths
in the LA than in the RA. Shorter local ERP and wavelength values
should translate into more rapid and stable local reentry. Subsequent
experimental studies have consistently demonstrated shorter
ERPs in the LA than in the
RA.7 8 15 16
LA regions with shorter refractory periods generate more organized
electrograms4 13 15
and, by virtue of more rapid intrinsic periods, appear to act as driver
regions that maintain AF by activating other areas with slower
periodicities.4 13
The available data suggest that the ERP differences between LA and RA
allow for more stable and rapid reentry in the LA than in the RA,
potentially contributing to the important role of the LA in
AF.
Ionic Mechanisms Underlying Atrial AP and
ERP Heterogeneity
There is growing awareness of the importance of
electrophysiological
heterogeneity at the atrial level. AP
heterogeneity within the canine RA is well
recognized,17 18 19
and we found that regional AP variability within the RA is associated
with distinct patterns of ionic current
density.19 In the
present study, ERP differences between canine LA and RA were
attributable to differences in APD. Furthermore, we found that LA free
wall myocytes have shorter APDs and larger
IKr
density than do RA cells from the free wall (pectinate muscles). In our
previous study, APD was similar in RA pectinate muscles and RA
appendage and longer in RA crista terminalis, areas with comparable
IKr
densities.19 Taken together,
the results of the present study and our previous work suggest that
IKr
density is greater and APD is shorter in the LA than in the RA
appendage, pectinate muscles, and crista terminalis. We are not aware
of any previous studies comparing ionic and/or AP properties between LA
and RA. At the ventricular level, Volders et
al20 showed that
midmyocardial cells from the canine right ventricle have larger
Ito and
IKs
density than do cells from the left ventricle.
Potential Significance
The present study is the first of which we are
aware that compares the ionic properties of atrial myocytes from the LA
with those from the RA, relating ionic differences to AP properties at
the single cell and multicellular level and also to ERP in vivo. Thus,
our findings add potentially important information regarding ionic
mechanisms of interatrial
electrophysiological variation.
The treatment of AF remains suboptimal. An improved understanding of the fundamental basis of atrial electrophysiological function should help in the development of improved therapeutic approaches. We have recently shown that intravenous dofetilide increases ERP to a greater extent in the LA than in the RA in dogs with a substrate for AF caused by either congestive heart failure or sustained atrial tachycardia.21 Dofetilide was highly effective in terminating heart failurerelated AF but was relatively ineffective in AF associated with atrial tachycardiainduced remodeling. In the latter group, dofetilide largely eliminated reentrant activity in the LA, but persistent reentry in the RA maintained AF. The findings of the present study may explain, at an ionic level, why dofetilide is more effective in prolonging canine atrial ERP and preventing atrial reentry in the LA than in the RA. Our results may also relate to recent studies of surgical therapy for AF that point to a role for the LA as a critical driver region for the arrhythmia.22 23
Potential Limitations
Several ionic currents, including in particular
IK24
and
IKur.d,
are quite sensitive to damage during cell isolation. We took
precautions to ensure that the same currents were studied in both LA
and RA myocytes isolated from the same dog on each experimental day.
For this reason, we could not compare the data from our previous
voltage-clamp study of RA ionic
heterogeneity19
with the results obtained in the LA in the present experiments. Any
differences noted could have simply been due to different qualities of
cell isolation enzymes and of cells available during the previous
experiments (performed 3 years before the present study) and the
present studies. Therefore, concurrent voltage-clamp studies for RA
had to be performed for direct comparison with LA myocytes. The greater
density of
IKr in
LA was supported by the independent observation of greater ERG protein
expression in the LA compared with the RA. Further evidence in support
of the main findings in isolated cells is provided by the fact that key
observations (including earlier repolarization in LA versus RA, a
larger effect of dofetilide in the LA, and equalization of LA-RA
repolarization in the presence of dofetilide) were reproducible in
multicellular atrial preparations and in the in situ heart.
Regional heterogeneity within the RA necessitates the consistent use of cells from one RA region as a basis for comparison with the LA. We studied RA cells from the pectinate muscle region, which represents a large proportion of the tissue in the RA free wall. Our results cannot be directly extrapolated to other RA regions, such as the appendix or crista terminalis; however, because our previous studies have shown that these areas have mean IKr densities similar to those in pectinate muscles and mean APDs that are equal to or greater than those in the pectinate muscle,19 it is likely that LA IKr is greater compared with values in the RA appendix and crista terminalis. Our studies of ERG protein expression support this notion, although we cannot exclude the possibility that there may be different ERG splice variants in LA versus RA, with differing affinities for the antibody that we used. RA cells in the AV ring region had a significantly larger IKr density than did cells from other RA regions in our previous study,19 with mean values close to those of LA cells in the present study. Therefore, the differences in RA versus LA IKr density found in the present study would not extend to comparisons between LA free wall and RA AV ring cells. We have previously found differences in ionic currents other than IKr within the RA.19 For example, L-type ICa is larger in the crista terminalis than in the pectinate muscles or the appendage (where it is equivalent). In addition, Ito is smaller in the RA appendage. Thus, potential regional differences within each atrium need to be considered, and although greater IKr is likely an important feature contributing to the shorter LA APD and ERP, it would be wrong to think that either atrium can be considered to have a single homogeneous set of ionic properties. We would have liked to examine the ionic properties of cells from other LA regions, such as the appendage, AV ring region, and pulmonary vein areas. Unfortunately, we found these areas difficult to perfuse effectively via single coronary arteries, so that the cells obtained were of variable and often poor quality. Any data obtained from such cells would be of questionable value; therefore, we elected to focus on the well-perfused LA free wall and the analogous RA free wall pectinate muscle region. Sampling limitations are always present in studies of this type; eg, the only published studies of right ventricular versus left ventricular ionic properties limited themselves to single regions of well-defined location in each ventricle.20 25
The present study examined repolarization properties of LA and RA, along with underlying ionic mechanisms. In no way do we wish to imply that repolarization differences are the only factor promoting LA arrhythmogenesis in AF. For example, the role of ectopic activity in the pulmonary vein region is now well recognized.26 27 Nonetheless, the ERP remains an important factor governing the rate and stability of reentry, and the differences noted in the present study are likely to be, at the very least, an important contributing factor to the role of the LA in maintaining AF.
Conclusions
We have shown that a larger
IKr
results in shorter APD and ERP in canine LA myocytes compared with RA
myocytes. These results have potential significance for determining the
interatrial differences in basic electrophysiology, the mechanisms
underlying AF, and the treatment of the
arrhythmia.>
|
Acknowledgments
This study was supported by the Medical Research Council of Canada and the Quebec Heart Foundation. Dofetilide was kindly supplied by Pfizer Pharmaceuticals. Dr Li is a Heart and Stroke Scientific Research Corporation of Canada/AstraZeneca research fellow. J. Kneller is a Medical Research Council of Canada student. The authors thank Chantal Maltais and Chantal St-Cyr for technical assistance.
Footnotes
Original received January 4, 2001; revision received April 9, 2001; accepted April 9, 2001.
References
This article has been cited by other articles:
![]() |
S. M. Narayan, D. Kazi, D. E. Krummen, and W.-J. Rappel Repolarization and Activation Restitution Near Human Pulmonary Veins and Atrial Fibrillation Initiation: A Mechanism for the Initiation of Atrial Fibrillation by Premature Beats J. Am. Coll. Cardiol., October 7, 2008; 52(15): 1222 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Etzion, M. Mor, A. Shalev, S. Dror, O. Etzion, A. Dagan, O. Beharier, A. Moran, and A. Katz New insights into the atrial electrophysiology of rodents using a novel modality: the miniature-bipolar hook electrode Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1460 - H1469. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. R. Rana, C. Zobel, E. Saygili, K. Brixius, F. Gramley, T. Schimpf, K. Mischke, D. Frechen, C. Knackstedt, R. H. G. Schwinger, et al. A simple device to apply equibiaxial strain to cells cultured on flexible membranes Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H532 - H540. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haissaguerre, K.-T. Lim, V. Jacquemet, M. Rotter, L. Dang, M. Hocini, S. Matsuo, S. Knecht, P. Jais, and N. Virag Atrial fibrillatory cycle length: computer simulation and potential clinical importance Europace, November 1, 2007; 9(suppl_6): vi64 - vi70. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruchat, N. Virag, L. Dang, J. Schlaepfer, E. Pruvot, and L. Kappenberger A biophysical model of atrial fibrillation ablation: what can a surgeon learn from a computer model? Europace, November 1, 2007; 9(suppl_6): vi71 - vi76. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gaborit, S. Le Bouter, V. Szuts, A. Varro, D. Escande, S. Nattel, and S. Demolombe Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart J. Physiol., July 15, 2007; 582(2): 675 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Hafid, H. C. Xin, W. Xi, Z. Q. Yan, and Y. Bo Difference between electrical remodelling after pulmonary veins and right atrium appendage pacing Europace, July 13, 2007; (2007) eum108v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruchat, L. Dang, J. Schlaepfer, N. Virag, L. K. von Segesser, and L. Kappenberger Use of a biophysical model of atrial fibrillation in the interpretation of the outcome of surgical ablation procedures Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 90 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cardin, E. Libby, P. Pelletier, S. Le Bouter, A. Shiroshita-Takeshita, N. Le Meur, J. Leger, S. Demolombe, A. Ponton, L. Glass, et al. Contrasting Gene Expression Profiles in Two Canine Models of Atrial Fibrillation Circ. Res., February 16, 2007; 100(3): 425 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruchat, L. Dang, N. Virag, J. Schlaepfer, L. K. von Segesser, and L. Kappenberger A biophysical model of atrial fibrillation to define the appropriate ablation pattern in modified maze Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 65 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shimoni, D. Hunt, K. Chen, T. Emmett, and G. Kargacin Differential autocrine modulation of atrial and ventricular potassium currents and of oxidative stress in diabetic rats Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1879 - H1888. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hu, S. V. P. Jones, and W. H. Dillmann Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1448 - H1455. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Duytschaever, Y. Blaauw, and M. Allessie Consequences of atrial electrical remodeling for the anti-arrhythmic action of class IC and class III drugs Cardiovasc Res, July 1, 2005; 67(1): 69 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mangin, A. Vinet, P. Pagé, and L. Glass Effects of antiarrhythmic drug therapy on atrioventricular nodal function during atrial fibrillation in humans Europace, January 1, 2005; 7(s2): S71 - S82. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Jacquemet, N. Virag, and L. Kappenberger Wavelength and vulnerability to atrial fibrillation: Insights from a computer model of human atria Europace, January 1, 2005; 7(s2): S83 - S92. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Melnyk, J. R. Ehrlich, M. Pourrier, L. Villeneuve, T.-J. Cha, and S. Nattel Comparison of ion channel distribution and expression in cardiomyocytes of canine pulmonary veins versus left atrium Cardiovasc Res, January 1, 2005; 65(1): 104 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nygren, A. E. Lomax, and W. R. Giles Heterogeneity of action potential durations in isolated mouse left and right atria recorded using voltage-sensitive dye mapping Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2634 - H2643. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kohl Cardiac cellular heterogeneity and remodelling Cardiovasc Res, November 1, 2004; 64(2): 195 - 197. [Full Text] [PDF] |
||||
![]() |
K. Zorn-Pauly, P. Schaffer, B. Pelzmann, P. Lang, H. Machler, B. Rigler, and B. Koidl If in left human atrium: a potential contributor to atrial ectopy Cardiovasc Res, November 1, 2004; 64(2): 250 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Dorian, I. Mangat, A. Pinter, and V. Korley The Burden of Atrial Fibrillation: Should We Abandon Antiarrhythmic Drug Therapy? Journal of Cardiovascular Pharmacology and Therapeutics, October 1, 2004; 9(4): 257 - 262. [Abstract] [PDF] |
||||
![]() |
T.-J. Cha, J. R. Ehrlich, L. Zhang, and S. Nattel Atrial Ionic Remodeling Induced by Atrial Tachycardia in the Presence of Congestive Heart Failure Circulation, September 21, 2004; 110(12): 1520 - 1526. [Abstract] [Full Text] [PDF] |
||||